We are thrilled to share that RetiSpec has been named to the CB Insights Digital Health 50 list for 2024, recognizing the world's 50 most promising private digital health companies! 🤩 This prestigious recognition highlights the innovation and impact of RetiSpec's AI-powered retinal imaging technology in advancing early detection for Alzheimer's disease. Being included among other trailblazing companies is a testament to the hard work and dedication of our team, partners, and supporters who believe in our mission; we're honoured to be in such incredible company. 🌎 As CB Insights notes, this year’s cohort represents critical shifts in healthcare, from AI-driven advancements to the prioritization of early detection and diagnostic innovations. At RetiSpec, we're proud to be part of this transformation. 💪 A huge thank you to CB Insights for this recognition and to everyone who has been part of our journey. We’re just getting started! 🚀 Read more about the Digital Health 50 and this year’s incredible cohort here: https://lnkd.in/giaQ5M3Y #DigitalHealth50 #AI #Innovation #Diagnostics #Healthcare #AlzheimersDetection #RetiSpec #HealthcareFromTheEye #HealthTech #Alzheimers #EndAlz
Boom: Meet the 2024 Digital Health 50, the most promising private healthcare companies across the globe. This year’s winners are working on everything from next-gen diagnostics to clinical intelligence. They span 9 countries, have raised $3.5B in equity funding, and 56 percent of winners are early-stage. See the full list and dive deep into the data on the 2024 cohort: https://cbi.team/4gehDGU #DigitalHealth50 #DH50